Myelomatous pleural effusion in multiple myeloma- A rare presentation

J Cancer Res Ther. 2024 Jan 1;20(1):476-478. doi: 10.4103/jcrt.jcrt_1772_22. Epub 2023 May 2.ABSTRACTMultiple myeloma is a malignant plasma cell condition that mostly affects the skeletal system and bone marrow. Pleural effusions are uncommon and typically result from other conditions coexisting with multiple myeloma. Malignant myelomatous pleural effusions are rare complications of multiple myeloma, occurring in less than 1% of patients and are associated with poor prognosis having mean survival of less than 4 months. The present case report is a 41-year-old multiple myeloma patient who developed bilateral pleural effusion at a disease relapse. Chemotherapeutic regimen of cyclophosphamide, bortezomib, and dexamethasone given. Despite a positive response to treatment, the patient's condition worsened over the course of following month and he eventually passed away. Myelomatous pleural effusion indicates poor prognosis and early consideration helps in quick diagnosis and initiation of treatment which may help in improving prognosis.PMID:38554369 | DOI:10.4103/jcrt.jcrt_1772_22
Source: Cell Research - Category: Cytology Authors: Source Type: research